Neurodevelopmental Disorders Across the Lifespan (NDAL)

Section Board

Josep Antoni RAMOS-QUIROGA, Chair

Philip ASHERSON, Co-Chair

Esther SOBANSKI, Secretary

Aims & Objectives

Section's mission

Neurodevelopmental disorders, like attention deficit hyperactivity disorder and autism spectrum disorders are impairments of the growth and development of the brain. These conditions typically have a childhood onset and persist into adult life, but there is a significant unmet clinical and research need to understand the persistence into adulthood. Neurodevelopmental disorders are associated with a significant mental, physical, and economic consequences for individuals, and in turn their families and society in general. 

The mission of the Section is to promote the improvement of mental health services to patients with neurodevelopmental disorders across lifespan via the creation of a forum in which research, training, diagnosis, and treatment can be explored in a specifically European context.

Aims

  1. To promote the training in neurodevelopmental disorders across lifespan.
  2. To enhance the knowledge about the persistence of neurodevelopmental disorders across lifespan.
  3. To improve diagnosis and treatment of neurodevelopmental disorders in adulthood.
  4. To promote research in neurodevelopmental disorders across life span in Europe.

Objectives

  1. To organize scientific and educational symposia during the annual European Congress of Psychiatry.
  2. To organize a Continuing Medical Education (CME) course on neurodevelopmental disorders across lifespan in collaboration with national psychiatry societies.
  3. Collaboration with other EPA sections.
  4. Collaboration with the WPA and ECNP in order to improve the management and the research of these disorders across life span.
  5. Networking with other European organizations, with a focus on neurodevelopmental disorders, such as the European Network of Adult ADHD or Family Caretakers Associations.
  6. To establish a platform for the creation of consortiums to increase the research in this field in Europe. 

Section's activities

1. Section symposium at EPA annual meeting.

2. Workshops at EPA congresses.

3. Educational materials about neurodevelopmental disorders across lifespan.

4. Publications (guidelines, results of collaborative research, etc…).

5. Strengthening collaboration between European psychiatrist in the field of research, knowledge transfer and exchange in the field of neurodevelopmental disorders across the lifespan. 

Section's objectives

  1. To promote the training in neurodevelopmental disorders across lifespan.

Activities

Meetings/events

SYMPOSIUM: NDAL: An overview

Description:

RENEWAL REPORT NDAL SECTION 2015-2017

 

The Section “Neurodevelopmental disorders across lifespan” (NDAL) has organized a business meeting per year since the approval of the Section. NDAL was promoted by a group of 15 psychiatrists interested in this field. The Section is now composed by 30 professionals. The elections of Chair (Prof. J. Antoni Ramos-Quiroga), co-Chair (Prof. Philip Asherson) and Secretary (Prof. Esther Sobanski) has been made as required.

 

NDLA has organized at the Congress in Vienna 2015, Madrid 2016 and in the next future congress in Florence 2017 the below 10 activities:

 

Activity 1:

Neurodevelopmental disorders across lifespan: An overview

Meeting: 23th European Congress of Psychiatry. Official Symposium of the Section. 

Date: March 29th 2015

Place: Vienna

Objectives: The symposium brought together investigators from different research areas who share an interest in the mechanisms that underlie neurodevelopmental disorders, whether they occur during early development or manifest later in life. Participants were provided with   a comprehensive review  of the clinical features of various neurodevelopmental disorders throughout the lifespan, the neurobiological basis and core neuropsychological underpinnings of these disorders and  with the available assessment and intervention options at various ages for various neurodevelopmental  and associated comorbid disorders.

 

Chair:  Josep Antoni Ramos-Quiroga, Spain 

Co-Chair:  Esther Sobanski, Germany 

Understanding comorbidity of neurodevelopmental disorders 

Symposium Speaker:  Philip Asherson, United Kingdom 

"ADHD: A neurodevelopmental disorder" 

Symposium Speaker:  Sandra Kooij, Netherlands 

"Autism: A neurodevelopmental disorder" 

Symposium Speaker:  van Elst van Elst, Germany 

"Schizophrenia as a neurodevelopmental disorder" 

Symposium Speaker:  Jacob Vorstman, Netherlands 

Activity 2: 

 

Symposium: ADHD - Lifecycle



Meeting: 23th European Congress of Psychiatry. Core Symposium. 

Date: March 31th 2015

Place: Vienna.

Objectives: The main objective of this symposium was to review ADHD across lifespan under several perspectives. We had the opportunity to present the last data about biological basis of ADHD, clinical features and treatment in adulthood.


 

Chair:  Istvan Bitter, Hungary 

 
 

Co-Chair:  Josep Antoni Ramos-Quiroga, Spain 

 

10:00 - 10:20

Biological basis of ADHD 

 
 

Invited Speaker:  Philip Asherson, United Kingdom 

 

10:20 - 10:40

Clinical presentation of ADHD 

 
 

Invited Speaker:  Esther Sobanski, Germany 

 

10:40 - 11:00

Treatment of ADHD through the Lifespan 

 
 

Invited Speaker:  Josep Antoni Ramos-Quiroga, Spain 

 

11:00 - 11:20

Comorbidity of ADHD - the role of age and sex  

 
 

Invited Speaker:  Istvan Bitter, Hungary 

 

11:20 - 11:30

Discussion              

 

 

 

 

 

 

 

 

 

Activity 3:

Symposium: Annual Meeting of the NDAL Section.

 

Meeting: 23th European Congress of Psychiatry. Core Symposium.

Date: March 301th 2015

Place: Vienna.

Objectives:  To organize the first official meeting of the NDAL section. The chair, co-chair and secretary was elected. Also, were approved objectives of the Section and future activities. 

 

 

Activity 4:

NDAL Section has organized an official symposium during the 24th European Congress of Psychiatry in Madrid, 2016.

 

“The role of emotional instability in adult ADHD borderline personality disorder, bipolar disorder, autism and intellectual disability: a transdiagnostic construct or disorder specific syndrome?”

 

  •  

Esther Sobanski, Mannheim, Germany

J. Antoni Ramos-Quiroga, Barcelona, Spain

 

  •  

Emotional instability and adult attention deficit hyperactivity disorder (ADHD)

Philip Asherson, London, United Kingdom

 

Emotional instability and borderline personality disorder:

Ulrich Ebner-Priemer, Karlsruhe, Germany

 

Emotional instability and bipolar disorder

Sophie Frangou, New York, USA

 

Emotional instability and autism and intellectual disability

Jane McCarthy, London, United Kingdom

 

 

 

 

 

 

 

 

 

Activity 5:

NDAL Section has organized an EPA Academia Educational Course entitled Attention-deficit/hyperactivity disorder (ADHD) in adults: nosology, diagnostic process and treatment” during the 24th European Congress of Psychiatry in Madrid.

 

Chair: Esther Sobanski

 

  •  

 

Background data, epidemiology, etiology, pathophysiology

Philip Asherson, London, United Kingdom

 

Clinical picture

Sandra Kooij, The Hague, Netherlands

 

Pharmacotherapy

J. Antoni Ramos-Quiroga, Barcelona, Spain

 

  •  

Esther Sobanski, Mannheim, Germany

 

 

Activity 6:

Symposium: Annual Meeting of the NDAL Section.

 

Meeting: 24th European Congress of Psychiatry. Core Symposium.

2016

Place: Madrid.

Objectives:  To organize the next activities of the NDAL section and to incorporate new members. To organize the update of the existing European Consensus on Adult ADHD.

 

 

 

 

 

 

 

 

Activity 7:

 

Florence 2017,

The NDLA will co-organize with the Section Addictive Behaviors the Workshop: Mental Health Impact of SUDS on Neurodevelopmental Mental Disorders

 

Hall F    Date: Sunday, April 2, 2017    From: 10:00    To: 11:30

 

Chair:  Josep Antoni Ramos-Quiroga, Spain

              

Chair:  Wim van den Brink, The Netherlands

              

10:00 - 10:22    Genetics of Substance Use Disorders and Neurodevelopmental Disorders

Josep Antoni Ramos-Quiroga, Spain

              

10:22 - 10:44    Neuroimage Studies: The Effect of Methylphenidate in Cocaine Users With ADHD

Cleo Crunelle, Belgium

              

10:44 - 11:06    Treatment of ADHD with Cannabinoids

Philip Asherson, United Kingdom

              

11:06 - 11:30    Guidelines for Managing ADHD and Substance Use Disorders            

Frieda Matthys, Belgium

 

 

 

 

 

 

 

 

 

 

 

Activity 8:

Florence 2017,

The NDLA will organize a Section Symposium: Modifying Outcomes of ADHD Across the Lifespan.

Hall B    Date: Monday, April 3, 2017    From: 10:00    To: 11:30

 

Chair:  Philip Gorwood, France  

Chair:  Josep Antoni Ramos-Quiroga, Spain

              

10:00 - 10:20    Continuity of ADHD Across the Lifespan             

Philip Asherson, United Kingdom

              

10:20 - 10:40    News on Pharmacological Treatment of ADHD Across the Lifespan         

Josep Antoni Ramos-Quiroga, Spain

              

10:40 - 11:00    ADHD and Addiction Across the Lifespan             

Wim van den Brink, The Netherlands

              

11:00 - 11:20    Non Pharmacological Treatment of ADHD Across the Lifespan       

Alexandra Philipsen, Germany

 

Activity 9:

 

Florence 2017,

 

The NDLA will organize a the EPA Academia Educational Course entitled  15: Attention-Deficit/Hyperactivity Disorder in Adults: Etiology, Nosology, Diagnostic Process and Multimodal Treatment

 

Hall D    Date: Tuesday, April 4, 2017    From: 08:00    To: 11:30

 

Chair:  Esther Sobanski, Germany

              

Chair:  Sandra Kooij, The Netherlands

              

Chair:  Josep Antoni Ramos-Quiroga, Spain

              

Chair:  Philip Asherson, United Kingdom

 

 

 

Activity 10:

Symposium: Annual Meeting of the NDAL Section.

 

Meeting: 25th European Congress of Psychiatry. Core Symposium.

2017

Place: Florence.

Objectives:  To organize the next activities of the NDAL section and to incorporate new members. To review and approved the update of the existing European Consensus on Adult ADHD. The plan is publish the new consensus in European Psychiatry.

 

 

 


SYMPOSIUM: NDAL: An overview

Description:

Neurodevelopmental disorders across lifespan: An overview

 

Chair:  Josep Antoni Ramos-Quiroga, Spain

 

 

Co-Chair:  Esther Sobanski, Germany

 

15:00 - 15:20

Understanding comorbidity of neurodevelopmental disorders 

 
 

Symposium Speaker:  Philip Asherson, United Kingdom 
 

 

15:20 - 15:40

"ADHD: A neurodevelopmental disorder" 

0045

 

Symposium Speaker:  Sandra Kooij, Netherlands 
 

 

15:40 - 16:00

"Autism: A neurodevelopmental disorder" 

 
 

Symposium Speaker:  van Elst van Elst, Germany 
 

 

16:00 - 16:20

"Schizophrenia as a neurodevelopmental disorder" 

 
 

Symposium Speaker:  Jacob Vorstman, Netherlands 
 

 

16:20 - 16:30

Discussion 

 

Date: 29/03/2015


Symposium: ADHD - Lifecycle

Description:

Symposium: ADHD - Lifecycle


 

Chair:  Istvan Bitter, Hungary

 

 

Co-Chair:  Josep Antoni Ramos-Quiroga, Spain

 

10:00 - 10:20

Biological basis of ADHD 

 
 

Invited Speaker:  Philip Asherson, United Kingdom

 

10:20 - 10:40

Clinical presentation of ADHD 

 
 

Invited Speaker:  Esther Sobanski, Germany

 

10:40 - 11:00

Treatment of ADHD through the Lifespan 

 
 

Invited Speaker:  Josep Antoni Ramos-Quiroga, Spain

 

11:00 - 11:20

Comorbidity of ADHD - the role of age and sex 3 

 
 

Invited Speaker:  Istvan Bitter, Hungary

 

11:20 - 11:30

Discussion              

 

Date: 31/03/2015


Publications

Presentations at non-section events

Other Section activities

Back to top